📰 Merck Sharp News
Page 30 - Merck Sharp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Merck Sharp. Real-time updates on events, politics, business and more.
July 7, 2023
Melody Akwetey, a mother of three kids who lives in Ablekuma-Joma, a suburb in the Ga Central Municipality of the Greater Accra region, said in an interview that her hunt for the Human Papillomavirus (HPV) vaccines in public clinics within her local community was fruitless until a friend recommended a…
July 6, 2023
/PRNewswire/ -- DelveInsights Esophageal Cancer Market Insights report includes a comprehensive understanding of current treatment practices, esophageal...
July 3, 2023
The new study shows a correlation between diabetes and poor outcomes for patients with metastatic non–small cell lung cancer (NSCLC) who received pembrolizumab.
July 3, 2023
/PRNewswire/ -- DelveInsights Bispecific Antibody Competitive Landscape – 2023 report provides comprehensive global coverage of available, marketed, and...
June 30, 2023
DUBLIN, June 29, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that its Par Sterile Products business has begun shipping posaconazole injection (18 mg/mL), the first generic version of Mercks Noxafil® in the U.S., followi...
June 30, 2023
TME PHARMA PROVIDES RESULTS OF ITS 2023 ANNUAL GENERAL MEETING OF SHAREHOLDERS AND ANNOUNCES THE RESUMPTION OF THE LIQUIDITY CONTRACT ...
June 29, 2023
/PRNewswire/ -- DelveInsights Liver Cancer Market Insights report includes a comprehensive understanding of current treatment practices, liver cancer emerging...
June 29, 2023
/PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that its Par Sterile Products business has begun shipping posaconazole injection (18...
June 28, 2023
TME PHARMA ANNOUNCES POSITIVE 15-MONTH SURVIVAL DATA FROM GLORIA EXPANSION ARM EVALUATING NOX-A12 IN COMBINATION WITH RADIOTHERAPY AND BEVACIZUMAB IN GLIOBLASTOMA 83% of glioblastoma patients remain alive a...
June 28, 2023
Study is designed to evaluate the potential for a synergistic effect of CAR-M therapy in combination with KEYTRUDA® PHILADELPHIA, June 28, 2023 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) (